Ex Vivo Human Placental Transfer of Rifampin and Rifabutin

Infectious Diseases in Obstetrics and Gynecology

Volumn 4, Issue 6, 1996, Pages 319-322

  Magee, Kevin P ^a   Wimberley, David ^a   Crane, Garen ^a   Sobhi, Sohrab ^a   Bawdon, Roger E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

maternal fetal transfer; rifabutin; rifampin

Indexed keywords

PHENAZONE; RIFABUTIN; RIFAMPICIN;

BLOOD PLACENTA BARRIER; CESAREAN SECTION; CONFERENCE PAPER; DRUG DETERMINATION; DRUG TRANSPORT; HUMAN; HUMAN TISSUE; PLACENTAL TRANSFER; PRIORITY JOURNAL; VAGINAL DELIVERY;

EID: 0030408685     PISSN: 10647449     EISSN: 10980997     Source Type: Journal    
DOI: 10.1155/S1064744996000646     Document Type: Article

References (11)

1. Hartman G, Honikel KO, Knusel F, Nuesch J: The specific inhibition of the DNA-directed RNA synthesis by rifamycin. Biochim Biophys Acta 145:843–844, 1967.
2. Umezawa H, Mizuno S, Yamazaki H, Nitta K: Inhibition of DNA dependent RNA synthesis by rifamycins. J Antibiot 21:234–236, 1968.
3. Nightingale SD, Cameron DW, Gordin FM, et al.: Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med 329:828–833, 1993.
4. Summam PM, Gordin FM, Wynne BA, et al.: Efficacy of rifabutin in the treatment of disseminated infection due to Mycobacterium avium complex. Clin Infect Dis 19:84–86, 1994.
5. Brogden RN, Fitton A: Rifabutin: A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 47:983–1009, 1994.
6. Snider DE, Layde PM, Johnson MW, Lyle MA: Treatment of tuberculosis during pregnancy. Am Rev Respir Dis 122:65–79, 1980.
7. Rocker I: Rifampicin in early pregnancy. Lancet 1:48, 1977.
8. Kenny MT, Strates B: Metabolism and pharmacokinetics of the antibiotic rifampin. Drug Metab Rev 12:159–218, 1981.
9. American Thoracic Society, Centers for Disease Control: Treatment of tuberculosis and tuberculous infection in adults and children. Am Rev Respir Dis 134:355, 1986.
10. Challier JC: Criteria for evaluating perfusion experiments and presentation of results. Contrib Gynecol Obstet 13:32–39, 1983.
11. Moore DJ, Perrino PJ, Klerer CP, Robertson P: Highperformance liquid chromatographic assay for two rifamycin-derived hypocholesterolemic agents in liver and biological fluids. J Chromatogr 612:310–314, 1993.